November 4, 2023
HemostOD enters EIT Health's Gold Track Programme
HemostOD has been recognized as a promising healthcare company by a jury of experts. The team will now receive tailored support to grow the company.
HemostOD has been recognized as a promising healthcare company by a jury of experts. The team will now receive tailored support to grow the company.
The EIT Health Gold Track Programme provides selected healthcare startups with access to mentorship, funding opportunities, and a network of industry experts across Europe. This recognition validates our innovative approach to platelet manufacturing and positions us for accelerated growth in the European healthcare market.
Learn more about the EIT Health Gold Track Programme.